deltatrials
Completed OBSERVATIONAL NCT00184327

Changes Following Inpatient Child-oriented Family Treatment

Change Across Intensive Inpatient Family Treatment in Child and Adolescent Psychiatry. A Multi-site Study of Parents and Children in Inpatient Family Treatment

Sponsor: Haukeland University Hospital

Conditions Psychiatric Disorders
Interventions Diagnostic assessment - child and adolescent psychiatry Intensive family therapy - inpatient
Updated 8 times since 2017 Last updated: Jan 16, 2017 Started: Jan 31, 2002 Primary completion: Dec 31, 2006 Completion: Jun 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Psychiatric Disorders, this trial is completed. The trial is conducted by Haukeland University Hospital and has accumulated 8 data snapshots since 2002. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Study Description(click to expand)

IFT is an intensive combinatory family treatment which is child-oriented, and traditionally used in an inpatient family treatment unit in child and adolescent psychiatry. Measures include ones on bonding (PBI), personality traits (NEO-PI), anxiety and depressive symptoms (HADS), attributional tendencies (PAT) and social desirable responding (BIDR). A subgroup was also assessed before a waiting period (pre-treatment).

IFT is an intensive combinatory family treatment which is child-oriented, and traditionally used in an inpatient family treatment unit in child and adolescent psychiatry.

Measures include ones on bonding (PBI), personality traits (NEO-PI), anxiety and depressive symptoms (HADS), attributional tendencies (PAT) and social desirable responding (BIDR). A subgroup was also assessed before a waiting period (pre-treatment).

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotCompleted~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed

  2. Sep 2024 — Present [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2022 — Jul 2024 [monthly]

    Completed

  5. Jan 2021 — Jan 2022 [monthly]

    Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed

  2. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: PHASE1 → None

  3. Jan 2017 — Apr 2018 [monthly]

    Completed PHASE1

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Haukeland University Hospital
  • Helse Nord-Trøndelag HF
  • Namsos Hospital
  • Norwegian University of Science and Technology
  • St. Olavs Hospital
Data source: Norwegian University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations